Subscribe to RSS

DOI: 10.5999/aps.2018.01431
Reconsidering the “MR Unsafe” breast tissue expander with magnetic infusion port: A case report and literature review

Breast tissue expanders (TEs) with magnetic infusion ports are labeled “MR Unsafe.” Therefore, patients with these implants are typically prevented from undergoing magnetic resonance imaging (MRI). We report a patient with a total submuscular breast TE who inadvertently underwent an MRI exam. She subsequently developed expander exposure, requiring explantation and autologous reconstruction. The safety profile of TEs with magnetic ports and the use of MRI in patients with these implants is surprisingly controversial. Therefore, we present our case report, a systematic literature review, and propose procedural guidelines to help ensure the safety of patients with TEs with magnetic ports that need to undergo MRI exams.
Publication History
Received: 02 December 2018
Accepted: 19 February 2019
Article published online:
28 March 2022
© 2019. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonCommercial License, permitting unrestricted noncommercial use, distribution, and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes. (https://creativecommons.org/licenses/by-nc/4.0/)
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
REFERENCES
- 1 American Society of Plastic Surgeons. Plastic surgery statistics report [Internet]. Arlington Heights, IL: American Society of Plastic Surgeons; c2017 [cited 2018 Nov 11]. https://www.plasticsurgery.org/documents/News/Statistics/2016/plastic-surgery-statistics-full-report-2016.pdf
- 2 Shellock FG. Reference manual for magnetic resonance safety, implants, and devices. 2019 Edition. Los Angeles: Biomedical Research Publishing Group; 2019: 244-7
- 3 Nava MB, Bertoldi S, Forti M. et al. Effects of the magnetic resonance field on breast tissue expanders. Aesthetic Plast Surg 2012; 36: 901-7
- 4 Marano AA, Henderson PW, Prince MR. et al. Effect of MRI on breast tissue expanders and recommendations for safe use. J Plast Reconstr Aesthet Surg 2017; 70: 1702-7
- 5 Thimmappa ND, Prince MR, Colen KL. et al. Breast tissue expanders with magnetic ports: clinical experience at 1.5 T. Plast Reconstr Surg 2016; 138: 1171-8
- 6 Fagan LL, Shellock FG, Brenner RJ. et al. Ex vivo evaluation of ferromagnetism, heating, and artifacts of breast tissue expanders exposed to a 1.5-T MR system. J Magn Reson Imaging 1995; 5: 614-6
- 7 Linnemeyer H, Shellock FG, Ahn CY. In vitro assessment of MRI issues at 3-Tesla for a breast tissue expander with a remote port. Magn Reson Imaging 2014; 32: 297-302
- 8 Park BS, Razjouyan A, Angelone LM. et al. RF Safety evaluation of a breast tissue expander device for MRI: numerical simulation and experiment. IEEE Trans Electromagn Compat 2017; 59: 1390-9
- 9 Mentor Worldwide LLC. Mentor tissue expander product insert data sheet [Internet]. Irvine, CA: Mentor Worldwide LLC; 2014. [cited 2018 Nov 15]. http://www.mentorwwllc.com/global-us/SafetyInformation.aspx
- 10 Zegzula HD, Lee WP. Infusion port dislodgement of bilateral breast tissue expanders after MRI. Ann Plast Surg 2001; 46: 46-8
- 11 Duffy Jr FJ, May Jr JW. Tissue expanders and magnetic resonance imaging: the “hot” breast implant. Ann Plast Surg 1995; 35: 647-9
- 12 Liang MD, Narayanan K, Kanal E. Magnetic ports in tissue expanders: a caution for MRI. Magn Reson Imaging 1989. 7. 541-2
- 13 Shellock FG. MRI Issues for implants and devices. In: Shellock FG, Crues JV, Karacozoff AM. MRI bioeffects, safety, and patient management. Los Angeles: Biomedical Research Publishing Group; 2014: 375-94
- 14 Shellock FG, Woods TO, Crues 3rd JV. MR labeling information for implants and devices: explanation of terminology. Radiology 2009; 253: 26-30
- 15 Nazarian S, Hansford R, Rahsepar AA. et al. Safety of magnetic resonance imaging in patients with cardiac devices. N Engl J Med 2017; 377: 2555-64